The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
- Sponsor
- Glaxo Wellcome
- Study ID
- NCT00002404
- Status
- Completed
Conditions
- HIV Infections
- Herpes Simplex
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir hydrochloride — DRUG
Study Details
The purpose of this study is to see if valacyclovir affects the detection of HIV in genital herpes lesions in HIV-infected patients. Valacyclovir is used to treat recurrent genital herpes.
Key Dates
- Status verified
- Jun 1999
Study Design
- Enrollment
- 30 participants
- Primary purpose
- TREATMENT
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.Recruiting · Syneos Health · Wilmington, North Carolina
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- Skeletal Muscle Energetics and Fatiguability in Older IndividualsRecruiting · Johns Hopkins University · Baltimore, Maryland